Lates News

Every AI Express, Guorui Securities issued a research report on August 11 giving a buy rating to Nine Continents Pharmaceutical (603456.SH). The reasons for the rating mainly include: 1) The main business performance is improving, with good cash flow performance; 2) The continuous enrichment of the CDMO project pipeline and smooth expansion of new customers; 3) The rapid development of the TIDES business unit and related technology platforms, actively promoting capacity expansion construction; 4) API business revenue is slightly fluctuating, with the gross profit margin continuously improving. (Daily Economic News)